Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00819208 · ClinicalTrials.gov registry record · NA

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

A NA study of Depression and Colorectal Cancer, sponsored by Canadian Cancer Trials Group.

Active
Registry status
NA
Development phase
889
Enrollment target
20
Study locations

NCT00819208: Active NA study of Depression and Colorectal Cancer, sponsored by Canadian Cancer Trials Group.

NCT00819208 is a NA study of Depression and Colorectal Cancer that is active but no longer recruiting, run by Canadian Cancer Trials Group. The registered enrollment target is 889 participants, above the 785-participant average among 679 other Depression trials with a reported enrollment target (13% higher). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00819208, a NA study of Depression and Colorectal Cancer, is active but no longer recruiting, sponsored by Canadian Cancer Trials Group.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
889 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Participating in a physical activity program designed to increase free time physical activity and receiving written health education materials may influence the chance of cancer recurring as well as impact on physical fitness, psychological well-being and the quality of life of patients who have undergone surgery and chemotherapy for colon cancer. It is not yet known whether giving a physical activity program together with health education materials is more effective than giving health education materials alone for patients who have undergone colon cancer treatment. PURPOSE: This randomized phase III trial is studying a physical activity program given together with health education materials to see how well it works compared with giving health education materials alone for patients who have undergone treatment for high-risk stage II or stage III colon cancer.

Primary Outcome

Time from randomization to the first event that was either recurrent (local or distant) colon cancer, a new primary colorectal cancer, a second primary cancer, or death from any cause. The outcome for the disease-free survival will be presented as 5 year disease-free survival rate.

Interventions

  • OTHER laboratory biomarker analysis
  • OTHER questionnaire administration
  • BEHAVIORAL exercise intervention
  • OTHER educational intervention
  • OTHER counseling intervention

Study Locations (20)

New South Wales

  • Armidale Hospital - Armidale
  • Bankstown-Lidcombe Hospital - Bankstown
  • Royal Prince Alfred Hospital - Camperdown
  • North Coast Cancer Institute Coffs Harbour - Coffs Harbour
  • Concord Repatriation General Hospital - Concord
  • Liverpool Hospital - Liverpool
  • Newcastle Private Hospital - Newcastle
  • North Coast Cancer Institute - Port Macquarie - Port Macquarie
  • Royal North Shore Hospital - St Leonards
  • Tamworth Hospital - Tamworth
  • Riverina Cancer Care Centre - Wagga Wagga
  • Sydney Adventist Hospital - Wahroonga

South Australia

  • Royal Adelaide Hospital - Adelaide
  • Flinders Medical Centre - Bedford Park
  • The Queen Elizabeth Hospital - Woodville

Queensland

  • Royal Brisbane and Women's Hospital - Herston
  • Princess Alexandra - Woolloongabba

Michigan

  • Henry Ford Hospital - Detroit

New Hampshire

  • Dartmouth-Hitchcock - Lebanon

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 889 participants
Start Date 2009-06-02
Est. Completion 2030-12-15
Phase NA
Canadian Cancer Trials Group

16 total trials

What the registry record for NCT00819208 still lists

NCT00819208 is an interventional study that assigns participants to a tested intervention. The registered 889 participants enrollment target is mid-sized for trials with a published cap, above the 785-participant average among 679 other Depression trials with a reported enrollment target (13% higher).

The record links to 8 conditions, with Depression appearing as the primary indexed condition, and to 5 interventions - of which laboratory biomarker analysis is the first listed.

NCT00819208 names 20 study sites across 6 states, led by New South Wales, South Australia, Queensland.

Frequently Asked Questions

What is clinical trial NCT00819208 about?

NCT00819208 is a clinical study titled "Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer". RATIONALE: Participating in a physical activity program designed to increase free time physical activity and receiving written health education materials may influence the chance of cancer recurring as well as impact on physical fitness, psychological well-being and the quality of life of patients w...

What is the current status of trial NCT00819208?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 889 participants. The study started on 2009-06-02. Estimated completion is 2030-12-15.

What conditions does trial NCT00819208 study?

This clinical trial studies the following conditions: Depression, Colorectal Cancer, Fatigue, Anxiety Disorder, Sleep Disorders.

What interventions are being tested in trial NCT00819208?

The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), exercise intervention (BEHAVIORAL), educational intervention (OTHER), counseling intervention (OTHER).

Who is sponsoring clinical trial NCT00819208?

This trial is sponsored by Canadian Cancer Trials Group, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00819208 being conducted?

This trial has 20 study locations across Michigan, New Hampshire, North Carolina, New South Wales, Queensland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00819208's enrollment target sits among peer trials

889 46th of 679 higher than 634 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03564340 · 890 participants · Phase 1

    Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

  • NCT05855200 · 892 participants · Phase 3

    Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  • NCT04862663 · 895 participants · Phase 3

    Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

  • NCT07196748 · 882 participants · Phase 3

    A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT00819208, the US trial registry maintained by the National Library of Medicine. NCT00819208 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.